| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.079 | 0.09 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |